This compound is a derivative of raloxifene, modified with a tert-butyldimethylsilyl (TBDMS) protecting group on the 4' phenol and retaining a hydroxy group at the 6-position. It is primarily used as a reference standard or impurity in active pharmaceutical ingredient (API) manufacturing for raloxifene-related products.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 174264-46-1
6-tert-Butyldimethylsilyl-4'-hydroxy Raloxifene
active pharmaceutical ingredient impurity
RALOXIFENE HYDROCHLORIDE
Active pharmaceutical ingredient
Raloxifene 6-Glucuronide
active pharmaceutical ingredient impurity
Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-|A-D-glycopyranuronate)
pharmaceutical impurity reference standard
Riluzol
active pharmaceutical ingredient
Amiloride hydrochloride dihydrate
active pharmaceutical ingredient
Raloxifene Bismethyl Ether
Pharmaceutical impurity reference standard
4-Hydroxy Raloxifene
active pharmaceutical ingredient
[2-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-6-hydroxy-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
YYSIXGNGLSNJGQ-UHFFFAOYSA-N
CC(C)(C)[Si](C)(C)OC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)OCCN5CCCCC5
—